May 03, 2023
95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studies HINGHAM, Mass. , May 03, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY Robotic system, the first fully disposable
Mar 23, 2023
Widely Published Interventional Radiologist Has Earned Well-Regarded Reputation Working with Prestigious Medical Centers in the U.S. and Europe The addition of Professor O’Sullivan, the Clinical Director of Radiology for the Galway Clinic in Ireland ,   E xpands the Company’s EU P resence.
Mar 16, 2023
Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal HINGHAM, Mass. , March 16, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.
Mar 13, 2023
Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization Objectives HINGHAM, Mass. , March 13, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.
Mar 09, 2023
HINGHAM, Mass. , March 09, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY ® Robotic System, the first single-use endovascular robotic system, today announced that an abstract was accepted for a podium presentation at the Israeli Conference on Robotics
Mar 02, 2023
Engagement with Interventional Radiologists Reaches Highest Level Yet as Company Continues to Progress Through Regulatory and Clinical Phases; Company Seeking to Create Interest and Anticipation for When the System is Commercialized HINGHAM, Mass. , March 02, 2023 (GLOBE NEWSWIRE) -- Microbot
Feb 28, 2023
Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans HINGHAM, Mass. , Feb. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced that Harel
Feb 27, 2023
Increases Key Opinion Leaders to 13 Throughout the Americas, Israel, and Europe to Support the Company’s Next Regulatory and Commercialization Paths for the LIBERTY® Robotic System HINGHAM, Mass. , Feb. 27, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc.
Feb 23, 2023
Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room , Potentially Minimizing Radiation Exposure and Reducing Physical Strain for the Healthcare Providers Design Patent Complements Existing U.S. and European Design Patents as Feedback During Recent Meetings Continues to

Displaying 46 - 54 of 154

Search Investor Relations